Dyadic co-learning program for men with prostate cancer and their spouses
Development and Exploring the Efficacy of a Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses
This program will test whether an 8-week co-learning course with weekly topics, a mobile app, and professional support helps men with prostate cancer and their cohabiting spouses feel better physically and emotionally and become more resilient.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 20 Years to 90 Years |
| Sex | All |
| Sponsor | National Taipei University of Nursing and Health Sciences Academic / other |
| Locations | 2 sites (Keelung and 1 other locations) |
| Trial ID | NCT07196488 on ClinicalTrials.gov |
What this trial studies
This is a randomized, two-group trial enrolling patient-spouse dyads from urology outpatient and inpatient services at two hospital sites in Taiwan. After baseline questionnaires, dyads are assigned 1:1 to routine care alone or routine care plus an 8-week Dyadic Co-learning Intervention that includes weekly learning modules, a mobile app, and professional support. Outcomes will be measured by questionnaires at baseline, 10 weeks, and 16 weeks to track changes in physical symptoms, emotional well-being, and resilience. The control group receives routine care only to compare effects of the co-learning program.
Who should consider this trial
Good fit: Men diagnosed with prostate adenocarcinoma who have chosen or completed treatment within the past two years, have ECOG performance status 0–1, and live with a spouse aged 20 or older who is functionally independent and willing to participate are ideal candidates.
Not a fit: Patients (or spouses) with another active cancer, cognitive impairment, psychiatric disorders, without a cohabiting spouse, or whose spouse cannot participate or use the mobile app are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, the program could reduce symptom burden, improve emotional well-being, and strengthen coping and support between patients and spouses.
How similar studies have performed: Previous couples- or dyad-focused psychosocial interventions in cancer have often shown positive effects on emotional well-being and coping, though results vary and mobile app–integrated dyadic co-learning is less extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: For Patients: 1. Diagnosed with prostate cancer by a board-certified urologist. 2. Has either decided on a treatment plan or completed treatment within the past two years. 3. Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. For Spouses: 1. Must be a cohabiting spouse of the prostate cancer patient and aged 20 years or older. 2. Must have a Barthel Index score of 91 or above, indicating good functional independence. Exclusion Criteria: Either the patient or the spouse will be excluded if: 1. Diagnosed with another type of cancer. 2. Diagnosed with cognitive impairment or a psychiatric disorder, such as dementia, depression, or anxiety.
Where this trial is running
Keelung and 1 other locations
- Keelung Chang Gung Memorial Hospital — Keelung, Taiwan (Not_yet_recruiting)
- LinKou Chang Gung Memorial Hospital — Taoyuan, Taiwan (Recruiting)
Study contacts
- Principal investigator: Ching-Hui Chien — National Taipei University of Nursing and Health Sciences, Taipei, Taiwan.
- Study coordinator: Ching-Hui Chien, PhD
- Email: chinghui@ntunhs.edu.tw
- Phone: +886-2-28227101
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.